Regeneron Partially Settles Patent Litigation With Genentech Over Eye Drug – NASDAQ

January 3, 2012 Posted By: Leave a comment
(RTTNews.com) - Regeneron Pharmaceuticals, Inc. (REGN) said Tuesday it has entered into a non-exclusive license and partial settlement of its patent litigation with Genentech Inc., a unit of Swiss drug maker Roche Group (RHHBY.PK), relating to U.S ...
Subscribe to LegalLaw247.Com Newsletter

Leave a Reply

Your email address will not be published. Required fields are marked *

*

CAPTCHA Image

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>